8-K - Northwest Biotherapeutics, Inc. | StockGist

Current Report Details

Event Type

Shareholder Vote

Charter Amendment

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.03

. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On December 30, 2025, the Company filed a Certificate of Amendment of its Amended an

Charter Amendment

5.07

. Submission of Matters to a Vote of Security Holders. Northwest Biotherapeutics, Inc. (the “Company”) held an annual meeting of stockholders on December 29, 20

Shareholder Vote

9.01

. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 3.1 Certificate of Amendment of the Amended and Restated Certificate of Incorporation

Exhibits Only

Exhibits (2)

3.1

EXHIBIT 3.1

8-K

FORM 8-K